Moreover, Anakinra treatment alleviated liver injury and inflammation without affecting fibrosis in a mouse model of CCl4-induced liver fibrosis, as shown by a decrease in caspase-1 and IL-1β with unchanged CTGF and TIMP expression (55). The gene discussed is CASP1; the disease is Hepatic fibrosis.